|
本帖最后由 naoli 于 2010-5-28 23:07 编辑
UK National Guidelines for HIV Testing 2008
恐友最关心的部分:
Which test to use?
There are two methods in routine practice for testing for HIV involving either venepuncture and a screening
assay where blood is sent to a laboratory for testing or a rapid point of care test (POCT).
Blood tests
The recommended first-line assay is one which tests for HIV antibody AND p24 antigen simultaneously.
These are termed fourth generation assays, and have the advantage of reducing the time between
infection and testing HIV positive to one month which is one to two weeks earlier than with sensitive third
generation (antibody only detection) assays [22]. It is reasonable to expect universal provision of these
assays, although they are not offered by all primary screening laboratories.
HIV RNA quantitative assays (viral load tests) are not recommended as screening assays because of the
possibility of false positive results, and also only marginal advantage over fourth generation assays for
detecting primary infection.
Confirmatory assays
Laboratories undertaking screening tests should be able to confirm antibody and antigen/RNA. There is a
requirement for three independent assays, able to distinguish HIV-1 from HIV-2. These tests could be
provided within the primary testing laboratory, or by a referral laboratory. All new HIV diagnoses should be
made following appropriate confirmatory assays and testing a second sample.
Testing including confirmation should follow the standards laid out by the Health Protection
Agency [23].
Point of care testing (POCT)
Point of care tests offer the advantage of a result from either a fingerprick or mouth swab sample within
minutes. They have advantages of ease of use when venepuncture is not possible, e.g. outside conventional
healthcare settings and where a delay in obtaining a result is a disadvantage, but these must be weighed
against the disadvantages of a test which has reduced specificity and reduced sensitivity versus current
fourth generation laboratory tests. Due to the low specificity of POCT and therefore the resulting poor
positive predictive value all positive results must be confirmed by serological tests as there will be false
positives, particularly in lower prevalence environments. Only CE-marked POCT kits should be used and a
nominated accredited pathology laboratory should assist with governance issues and quality assurance of
the testing process.
POCT is therefore recommended in the following contexts (see BASHH Point of Care Testing
Guidance) [24]:
1. clinical settings where a rapid turnaround of testing results is desirable
2. community testing sites
3. urgent source testing in cases of exposure incidents
4. circumstances in which venepuncture is refused. |
|